Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Vasiliki Gkalea, Xavier Amiot, Thierry Jo Molina, Laurent Frenzel & Claude Bachmeyer. (2021) Intraperitoneal bleeding as the initial presentation of Randall-type monoclonal immunoglobulin deposition disease with hepatic involvement. Leukemia & Lymphoma 62:5, pages 1263-1266.
Read now
Read now
Di Wang, Yan Wang & Shiren Sun. (2021) Renal pathological changes after successful treatment of LCDD using cyclophosphamide, thalidomide, and dexamethasone. Renal Failure 43:1, pages 1425-1427.
Read now
Read now
Dimitrios C. Ziogas, Efstathios Kastritis, Evangelos Terpos, Maria Roussou, Magdalini Migkou, Maria Gavriatopoulou, Despoina Spanomichou, Evangelos Eleutherakis-Papaiakovou, Despoina Fotiou, Ioannis Panagiotidis, Eftychia Kafantari, Erasmia Psimenou, Ioannis Boletis, Demetrios V. Vlahakos, Hariklia Gakiopoulou, Charis Matsouka & Meletios A. Dimopoulos. (2017) Hematologic and renal improvement of monoclonal immunoglobulin deposition disease after treatment with bortezomib-based regimens. Leukemia & Lymphoma 58:8, pages 1832-1839.
Read now
Read now
Morie A. Gertz. (2012) Managing light chain deposition disease. Leukemia & Lymphoma 53:2, pages 183-184.
Read now
Read now
Articles from other publishers (14)
Angsupat Pornchai & Teng Moua. (2023) Dyspnea and cough in a 68-year-old female with light chain deposition disease. Respiratory Medicine Case Reports 43, pages 101839.
Crossref
Crossref
LEAL HERLITZ & JUAN C. CALLE. 2020. Onco-Nephrology. Onco-Nephrology
76
84.e3
.
Jing Huang, Chunyan Sun, Hua Su, Chun Zhang & Jing Xiong. (2019) Bortezomib-Based Chemotherapy with Autologous Stem Cell Transplantation for Monoclonal Gammopathy of Renal Significance: A Case Report and Literature Review. Kidney and Blood Pressure Research 44:4, pages 858-869.
Crossref
Crossref
Mojgan Esparvarinha, Hamid Nickho, Hamed Mohammadi, Leili Aghebati-Maleki, Jalal Abdolalizadeh & Jafar Majidi. (2017) The role of free kappa and lambda light chains in the pathogenesis and treatment of inflammatory diseases. Biomedicine & Pharmacotherapy 91, pages 632-644.
Crossref
Crossref
Nelson Leung & Samih H. Nasr. 2017. Biology and Management of Unusual Plasma Cell Dyscrasias. Biology and Management of Unusual Plasma Cell Dyscrasias
163
194
.
Dharshan Sivaraj, Michael Martin Green, Abdullah Mucahit Ciftci, Mohammad Faizan Zahid, Angela Anne Johns, Maureen Ross & Cristina Gasparetto. (2016) Can We Cure Light Chain Deposition Disease of the Kidneys??A Review and Case Report of a Patient Treated With a Triple Transplant Approach. Clinical Lymphoma Myeloma and Leukemia 16:6, pages e95-e100.
Crossref
Crossref
Bappa Adamu, Mushabab Al-Ghamdi, Mustafa Ahmad & Khaled O. Alsaad. (2016) Treatment of Light Chain Deposition Disease Using Bortezomib-Based Regimen Followed by Thalidomide-Based Regimen in a Saudi Male. Case Reports in Nephrology 2016, pages 1-4.
Crossref
Crossref
S. Kuppachi, D. Holanda & C.P. Thomas. (2016) Light Chain Deposition Disease After Kidney Transplantation With Long Graft Survival: Case Report. Transplantation Proceedings 48:1, pages 255-258.
Crossref
Crossref
Yukihiro Wada, Masayuki Iyoda, Tomohiro Saito, Noriko Arai-Nunota, Ken Iseri, Eiko Tomita, Misa Ikeda, Yutaka Yamaguchi & Takanori Shibata. (2015) Light-Chain Deposition Disease Successfully Treated with Bortezomib in an Elderly Patient: A Case Report and Review of the Literature. Internal Medicine 54:22, pages 2893-2898.
Crossref
Crossref
Nelson Leung & Samih H. Nasr. 2015. Onconephrology. Onconephrology
251
277
.
Maria Gkotzamanidou, Evangelos Terpos, Efstathios Kastritis & Meletios Athanasios Dimopoulos. (2014) Hematologic Response and Stabilization of Renal Function in a Patient With Light Chain Deposition Disease After Lenalidomide Treatment: A Novel Therapeutic Approach?. Clinical Lymphoma Myeloma and Leukemia 14:5, pages e179-e181.
Crossref
Crossref
Nelson Leung & Samih H. Nasr. (2014) Myeloma-related Kidney Disease. Advances in Chronic Kidney Disease 21:1, pages 36-47.
Crossref
Crossref
Natalia Tovar, Ma Teresa Cibeira, Laura Rosi?ol, Manel Sol?Carlos Fern?ndez Larrea, Lourdes Escoda, Montserrat Rovira & Joan Blad?. (2012) Bortezomib/dexamethasone followed by autologous stem cell transplantation as front line treatment for light-chain deposition disease. European Journal of Haematology 89:4, pages 340-344.
Crossref
Crossref
V. H. JIMENEZ-ZEPEDA. (2012) Light chain deposition disease: novel biological insights and treatment advances. International Journal of Laboratory Hematology 34:4, pages 347-355.
Crossref
Crossref